Marketing-authorisation holder · United States
Quad Pharms
29 medicines in 1 country, as authorisation holder.
Group structure
Part of
QUADPharmaceutical groupOther companies in the group
Canada1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 29
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAZOLAMIDE SODIUM500mg base/vial · Injectable | Acetazolamide | United States | Marketed | 1995 |
| AZATHIOPRINE100mg base/vial · Injectable | Azathioprine | United States | Not marketed | |
| BACITRACIN10,000 units/vial | 50,000 units/vial · Injectable | Bacitracin | United States | Not marketed | |
| BETHANECHOL CHLORIDE5mg/ml · Injectable | Bethanechol | United States | Not marketed | |
| CHORIONIC GONADOTROPIN10,000 units/vial | 15,000 units/vial | 2,000 units/vial | 20,000 units/vial | 5,000 units/vial · Injectable | Gonadotropin, Chorionic | United States | Marketed | 1973 |
| DACARBAZINE100mg/vial | 200mg/vial | 500mg/vial · Injectable | Dacarbazine | United States | Marketed | 1986 |
| ESTRADIOL CYPIONATE5mg/ml · Injectable | Estradiol cypionate | United States | Not marketed | 1981 |
| FLUPHENAZINE25mg/ml · Injectable | Fluphenazine | United States | Not marketed | |
| FLUPHENAZINE HCL2.5mg/ml · Injectable | Fluphenazine | United States | Not marketed | |
| GLUCAGON10MG BASE/VIAL | 10MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG BASE/VIAL | 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Glucagon | United States | Not marketed | 1960 |
| HYDROCORTISONE SODIUM PHOSPHATE50mg base/ml · Injectable | Hydrocortisone | United States | Not marketed | |
| HYDROXYPROGESTERONE CAPROATE125mg/ml | 250mg/ml · Injectable | Hydroxyprogesterone caproate | United States | Not marketed | 1974 |
| KETAMINE HCL100mg base/ml | 10mg base/ml | 50mg base/ml · Injectable | Ketamine | United States | Not marketed | |
| LINCOMYCIN HCL300mg base/ml · Injectable | Lincomycin | United States | Not marketed | |
| METHOTREXATE SODIUM100mg base/4ml (eq 25mg base/ml) | 100mg base/vial | 1gm base/40ml (eq 25mg base/ml) | 2.5mg base/ml | 200mg base/8ml (eq 25mg base/ml) | 20mg base/vial | 250mg base/10ml (eq 25mg base/ml) | 250mg base/vial | 25mg base/ml | 50mg base/2ml (eq 25mg base/ml) | 50mg base/vial · Injectable | Methotrexate | United States | Marketed | 1959 |
| METHYLDOPATE HCL50mg/ml · Injectable | Methyldopa | United States | Not marketed | |
| METOCLOPRAMIDE HCL10mg base/2ml · Injectable | Metoclopramide | United States | Not marketed | |
| METOCURINE IODIDE2mg/ml · Injectable | Dimethyltubocurarine | United States | Not marketed | |
| NALBUPHINE10mg/ml | 20mg/ml · Injectable | Nalbufine | United States | Not marketed | |
| NALOXONE HCL0.02mg/ml | 0.4mg/ml | 1mg/ml · Injectable | Naloxone | United States | Not marketed | |
| PROCAINAMIDE HCL100mg/ml | 500mg/ml · Injectable | Procainamide | United States | Not marketed | |
| PROTAMINE SULFATE10mg/ml | 50mg/vial · Injectable | Protamine | United States | Not marketed | |
| RITODRINE HCL10mg/ml | 15mg/ml · Injectable | Ritodrine | United States | Not marketed | |
| SULFAMETHOPRIM80mg/ml; 16mg/ml · Injectable | Sulfamethoxazole, Trimethoprim | United States | Not marketed | |
| TESTOSTERONE CYPIONATE100mg/ml | 200mg/ml · Injectable | Testosterone | United States | Marketed | 1978 |